MedTrace Logo

Dietary Fibers Effect on the Gut Microbiota Composition

NCT04114513 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2021-03-12

No results posted yet for this study

Summary

The randomized double-blinded placebo-controlled multicenter study will be held in parallel groups. During 5 weeks the efficacy of different endpoints as a measure of response to the daily intake of dietary fibers (8 g of either inulin, pectin, beta-glucan or galactooligosaccharides) will be evaluated. Gut microbiota composition, lipids levels, inflammation markers, microbiome metabolites, changes in quality of life and stool parameters will be assessed in order to predict individual response in participants without serious chronic diseases

Conditions

  • Microbiome
  • Metabolic Syndrome
  • Cardiovascular Risk Factor
  • Inflammation
  • Dyslipidemias

Interventions

DIETARY_SUPPLEMENT

Maltodextrin

NOVAPRODUKT, white powder 5 weeks intervention

DIETARY_SUPPLEMENT

Inulin

BENEO-Orafti, white powder 5 weeks intervention

DIETARY_SUPPLEMENT

Pectin

BANG \& BONSOMER GROUP OY, white powder 5 weeks intervention

DIETARY_SUPPLEMENT

Beta-glucan

Tate \& Lyle, white powder 5 weeks intervention

DIETARY_SUPPLEMENT

Galactooligosaccharides

FrieslandCampina, white powder 5 weeks intervention

Sponsors & Collaborators

  • Atlas Biomed

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-11-25
Primary Completion
2020-09-01
Completion
2020-09-30

Countries

  • Russia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04114513 on ClinicalTrials.gov